Data as of May 17
| -0.01 / -1.75%|
The 2 analysts offering 12-month price forecasts for Savient Pharmaceuticals Inc have a median target of 1.00, with a high estimate of 1.00 and a low estimate of 1.00. The median estimate represents a +78.57% increase from the last price of 0.56.
The current consensus among 4 polled investment analysts is to Hold stock in Savient Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.